• Register
  • Login

Iranian Journal of Pharmaceutical Sciences

  • Home
  • Journal Info
    • About the Journal
    • Aims and Scope
    • Editorial Team
    • Indexing & Abstracting
    • Privacy Statement
    • Contact us
  • Issues
    • Current
    • Archives
  • New Submissions
  • Author Guidelines
  • Policies & Process
    • Peer Review
    • Publication Ethics
    • Open Access Policy
    • Plagiarism
    • Retraction Policies
    • Archiving
  • Ethical Considration
Advanced Search
  1. Home
  2. Archives
  3. Vol. 6 No. 1 (2010): IJPS_Volume 6_Issue 1 (2010)
  4. Research/Original Articles

Vol. 6 No. 1 (2010)

January 2010

The Erythrocyte Catalase Enzyme Activity in Iranian Osteoporotic Women Catalase and bone mineral density

  • Behrooz Jannat
  • Mohammad-Reza Oveisi
  • Naficeh Sadeghi
  • Mannan Hajimahmoodi
  • Golnaz Izadi Dolagh
  • Masoomeh Behzad
  • Ahmad-Reza Jamshidi
  • Abdol-azim Behfar
  • Kheir-ollah Gholami

Iranian Journal of Pharmaceutical Sciences, Vol. 6 No. 1 (2010), 15 January 2010 , Page 19-24
https://doi.org/10.22037/ijps.v6.41234

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Osteoporosis is a disease of high prevalence with increased bone loss. It has potential public health threat and that the health authorities had taken several measures for its control. In recent years, considerable attention has been given to physiopathology of osteoporosis. Oxidative stress has been proved to be involved in bone resorption. Oxidative stress occurs when balance between oxidants and biochemical antioxidants is disrupted because of excess reactive oxygen species. Thus, we measured catalase activity, as one of the marker of stress oxidative, in 138 women. Participants were selected by inclusion and exclusion criteria from those who were referred to Jamie Clinic in Tehran for BMD evaluation. Catalase antioxidant activity was 262.01±44.70 k/gHb in the group of subjects with osteoporosis in comparison with the group of healthy subjects, 273.77±46.92 k/gHb. The results show that catalase activity in patients with bone deficiency was less than in the control group, though it was not significant. This difference was more between control and patients group with more acute disease (T score -1.7) than patients group with milder disease (T score<-1).The results show that it may be useful to monitor osteoporosis in the more expanded sample size to obtain more definition results.

Keywords:
  • Catalase activity
  • Iranian women
  • Osteoporosis
  • Oxidative stress
  • IJPS_Volume 6_Issue 1_Pages 19-24

How to Cite

Behrooz Jannat, Mohammad-Reza Oveisi, Naficeh Sadeghi, Mannan Hajimahmoodi, Golnaz Izadi Dolagh, Masoomeh Behzad, … Kheir-ollah Gholami. (2010). The Erythrocyte Catalase Enzyme Activity in Iranian Osteoporotic Women: Catalase and bone mineral density. Iranian Journal of Pharmaceutical Sciences, 6(1), 19–24. https://doi.org/10.22037/ijps.v6.41234
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

[1] Fatokum AA, Stone TW, Smith RA. Response of different MC3T3-E1 osteoblast like cells to reactive oxygen species. Eur J Pharmacol 2008; 587: 35-41.
[2] Chavan S, More U, Mulgund SH, Saxena V, Sontakke A. Effect of supplementation of vitamin C and E on oxidative stress in osteoposis. Indian J Clin Biochem 2007; 22: 101-5.
[3] Chin AI. Melatonin and its Role in aging and oxidative stress. Nutr Bytes 1996; 2: issue 1.
[4] Masella R, Di Benedetto R, Vari R. Novel mechanism of natural antioxidant compounds is biological system. Involvement of glutathione and glutathione-related enzymes. J Nutr Biochem 2005; 16: 577-86.
[5] Ozgocmen S, Kaya H, Fadillioglu E, Aydogan R, Yilmaz Z. Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osterporosis. Mol Cell Biochem 2007; 295: 45-52.
[6] Sanchez-Rodriguez M, Ruiz-Ramos M, Correa-Munoz E, Mendoza-Nunez V. Oxidative stress as a risk factor for osteoporosis in elderly Mexican as characterized by antioxidant enzymes. BMC Musculoskelet Disord 2007; 8:124.
[7] McCormick K. Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility. Markers Oxidative Damage 2007; 1: 1-10.
[8] Abei H. Methods of enzymatic analysis. New York: Academic press, 1974; pp. 673-7.
[9] Kourie JI. Interaction of reactive oxygen species with ion transport mechanism. Am J Physiol Cell Physiol 1998; 275: 1-24.
[10] Isomura H, Fujie K, Shibata K, Inoue N, Iizuka T, Takebe G, Takahashi K, Nishihira J, Izumi H, Sakamoto W. Bone metabolism and oxidative stress in postmenopausal rats with iron overload. Toxicology 2004; 197: 93-100.
[11] Arai M, Shibata Y, Pugdee K, Abiko Y, Ogata Y. Effects of reactive oxygen species on antioxidant system and osteoblastic differentiation in MC3T3-E1 cells. IUBMB Life 2008; 59: 27-33.
[12] Altindag Z, Erel O, Soran N, Celik H, Selek S. Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol Int 2008; 28: 317-21.
[13] Costa LG. Biomarkers research in neurotoxicology: the role of mechanistic studies to bridge the gap between the laboratory and epidemiological investigations. Environ Health Persp 1996; 104:
55-62.
[14] Leite MF, Ganzerla E, Marques MM, Nicolau J.Diabetes induces metabolic alterations in dental pulp. J Endod 2008; 34: 1211-4.
[15] Masayo F, Makoto K, Yasushi T, Yasuyuki A.Analysis of serum catalase activities in pancreatic disease. J Gastroenterol 2004; 39: 469-74.
[16] Miller JD, Chu Y, Brooks RM, Richenbacher WE, Peña-Silva R, Heistad DD. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J Am Coll Cardiol 2008; 52: 843-50.
[17] Looi ML, Mohd Dali AZ, Md Ali SA, Wan Ngah WZ, Mohd Yusof YA. Oxidative damage and antioxidant status in patients with cervical intraepithelial neoplasia and carcinoma of the cervix. Eur J Cancer Prev 2008; 17: 555-60.
[18] Sadeghi N, Oveisi MR, Jannat B, Hajimahmoodi M, Jamshidi AR, Sajadian Z. Determination of plasma gluthatione reductase enzyme activity in osteoporotic women. Daru 2008; 16: 51-4.
[19] Oveisi MR, Sadeghi N, Jannat B, Hajimahmoodi M, Hajibabai M, Jamshidi AR, Javadi S, Korouji M. The relation of the plasma ascorbic acid and bone mineral density in women referring to Jami clinic, Tehran, Iran. IJPS 2008;4:249-54.
[20] Hajimahmoodi M, Sadeghi N, Hajibabai M, Jannat B, Jamshidi AR, Mirabzadeh M. Vitamin E plasma concentration in osteoprotic patients. Tehran U Med J 2007;65:79-85.
[21] Behfar AA, Sadeghi N, Oveisi MR, Jannat B, Hajimahmoodi M, Jamshidi AR, Rastegary P.The plasma antioxidant activity of enzyme activity in osteoporotic women. Acta Med Iranica 2008;46:441-6.
[22] Yang Z, Zhang Z, Penniston KL, Binkley N, Tanumihardjo SA. Serum carotenoid concentrations in postmenopausal women from the United States with and without osteoporosis. Int J Vitam Nutr 2008; 78: 105-11.
[23] Rao LG, Mackinnon ES, Rao AV. Lycopene intake significantly reduces biomarkers oxidative stress and bone resorption in postmenopausal women. Acta Horticulturae 2007; 18: 109-15.
[24] Knight JA. Disease related to oxygen-derived free radicals. Ann Clin Lab Sci 1995; 25: 111-21.
  • Abstract Viewed: 341 times
  • IJPS_Volume 6_Issue 1_Pages 19-24 Downloaded: 217 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Developed By

Open Journal Systems

Information

  • For Readers
  • For Authors
  • For Librarians
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Creative Commons License
This journal (and its contents) is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Print ISSN: 1735-2444

Online ISSN: 2252-0457

Powered by OJSPlus